962 Shares in Humana Inc. (NYSE:HUM) Purchased by Secure Asset Management LLC

Secure Asset Management LLC acquired a new stake in Humana Inc. (NYSE:HUM) during the fourth quarter, Holdings Channel reports. The firm acquired 962 shares of the insurance provider’s stock, valued at approximately $244,000.

Several other institutional investors have also added to or reduced their stakes in the business. International Assets Investment Management LLC raised its position in shares of Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after purchasing an additional 738,701 shares during the period. FMR LLC raised its holdings in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after acquiring an additional 643,291 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of Humana by 55.6% during the third quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after acquiring an additional 214,535 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after acquiring an additional 187,903 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new position in shares of Humana in the third quarter worth $50,102,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

Humana stock opened at $294.47 on Friday. The firm has a fifty day simple moving average of $274.39 and a two-hundred day simple moving average of $305.26. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a market capitalization of $35.46 billion, a PE ratio of 26.08, a P/E/G ratio of 2.15 and a beta of 0.55. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Research analysts expect that Humana Inc. will post 16.11 EPS for the current year.

Analyst Ratings Changes

HUM has been the topic of a number of recent research reports. Wells Fargo & Company dropped their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. KeyCorp assumed coverage on shares of Humana in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Piper Sandler upped their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and raised their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, Barclays upped their price target on shares of Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a report on Wednesday. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $302.80.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.32% of the stock is owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.